CPHI / China Pharma Holdings, Inc. - Institutional Ownership - Buyers

China Pharma Holdings, Inc.
US ˙ NYSEAM ˙ US16941T1043

Institutional and Fund Ownership - Buyers

Major holders that have opened new positions in China Pharma Holdings, Inc. include UBS Group AG, Citadel Advisors Llc, Hrt Financial Lp, Tower Research Capital LLC (TRC), and Proequities, Inc. .

This page shows changes in the ownership structure by listing institutions, funds, and major shareholders that have increased their holdings or opened new positions in the last reporting period. Green rows indicate new positions. Click the link icon to see the full transaction history.

Upgradeto unlock premium data.

File Date Source Investor Type Avg Price
(Est)
Shares Δ Shares
(%)
Reported
Value
($1000)
Δ Value
(%)
Port Alloc
(%)
2025-08-12 13F Proequities, Inc. 0 0
2025-08-15 13F Tower Research Capital LLC (TRC) 8,213 15
2025-08-14 13F Citadel Advisors Llc 23,070 41
2025-08-14 13F UBS Group AG 71,233 128
2025-08-14 13F Hrt Financial Lp 16,168 0
Other Listings
DE:XQJ0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista